Skip to main page content

• HOME
• Current Issue
• Archive
• Alerts
• About ASM
• Contact us
• Tech Support
• Journals.ASM.org

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hernould, M. Articles by Arpin, C. Search for Related Content PubMed PubMed Citation Articles by Hernould, M. Articles by Arpin, C.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, April 2008, p. 1559-1563, Vol. 52, No. 4
0066-4804/08/$08.00+0     doi:10.1128/AAC.01052-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Role of the AheABC Efflux Pump in Aeromonas hydrophila Intrinsic Multidrug Resistance

Mathieu Hernould, Séverine Gagné, Michel Fournier, Claudine Quentin, and Corinne Arpin^*

CNRS UMR 5234, Université de Bordeaux 2, 146 rue Léo Saignat, 33076 Bordeaux Cedex, France

Received 10 August 2007/ Returned for modification 10 October 2007/ Accepted 30 January 2008

Top ABSTRACT TEXT REFERENCES

 
Gene inactivation and complementation experiments showed that the tripartite AheABC efflux pump of Aeromonas hydrophila extruded at least 13 substrates, including nine antibiotics. The use of phenylalanine-arginine-β-naphthylamide (PAβN) revealed an additional system(s) contributing to intrinsic resistance. This is the first analysis of the role of multidrug efflux systems in Aeromonas spp.

Top ABSTRACT TEXT REFERENCES

 
Aeromonas hydrophila is a gram-negative bacillus living in a variety of aquatic environments (1). This organism is occasionally responsible for human infections following contact with contaminated water or derived products. Clinical manifestations include gastroenteritis, skin and soft tissue infections, and a series of clinical syndromes that appear in immunocompromised patients (11). Among Aeromonas spp., multidrug resistance (MDR) phenotypes were observed (7, 8, 9), some of which were reversed by the efflux pump inhibitor phenylalanine-arginine-β-naphthylamide (PAβN) (7, 14). To date, no functional data are available for MDR efflux pumps in Aeromonas species. However, these systems, especially those belonging to the resistance-nodulation-cell division (RND) family, are known to play a major role in the antimicrobial resistance of various environmental gram-negative bacilli that behave as opportunistic pathogens (18).

The 4.7-Mb genome of A. hydrophila subsp. hydrophila ATCC 7966^T has recently been sequenced (21). Ten RND systems have been detected, including seven belonging to the hydrophobe/amphiphile efflux-1 family (20, 21). Among them, AHA2910, renamed AheB (Aeromonas hydrophila efflux B), is the pump most closely related to that of the major AcrB system of Escherichia coli. The aheA (1,194 bp) and aheC (1,434 bp) genes are located immediately upstream and downstream of aheB (3,150 bp), respectively. aheA, aheB, and aheC are in the same orientation and are organized in an operon-like structure (Fig. 1). Their deduced protein sequences share the highest identities with the membrane fusion protein AcrA of Photorhabdus luminescens (54%), the RND efflux pump AcrB of E. coli (69%), and the outer-membrane protein TtgC of Pseudomonas entomophila (58%), respectively. Another open reading frame (642 bp), called aheR, situated 143 bp upstream and in the opposite orientation of aheABC, exhibits sequence identity with the transcriptional repressors of the TetR family, such as AcrR of E. coli (37.6%) (Fig. 1).

View larger version (16K): [in this window] [in a new window]

FIG. 1. Schematic representation of the aheRABC gene cluster and aheB inactivation strategy. Open arrows show the position and orientation of the aheR, aheA, aheB and aheC genes. At the top of the figure, the horizontal thin arrows indicate the position and orientation of primers used for amplification experiments and are numbered as follows: 1, aheB1F1; 2, MotifD1; 3, MotifAF_KpnI; 4, MotifAR_SalI; 5, MotifDF_BamHI; 6, MotifDR_SphI; 7, yAheAdbt and 8, yAheCfnR. Oligonucleotides with a 5'-end modification (i.e., introduction of restriction site or DNA yeast sequences) are represented by horizontal thin black arrows with a tail. The amplicons A and D (white boxes) possess cohesive ends (in gray) when digested by KpnI and SalI (amplicon A) and by BamHI and SphI (amplicon D) restriction enzymes. After ligation with the kanamycin resistance gene (kanR, as a hatched box), the AKD fragment was obtained. By double crossover between the chromosomal aheB gene and the homologous sequences situated on pEX-AKD plasmid, a aheB::kan mutant was constructed.

The aims of the present study were to investigate the role of the tripartite RND efflux pump AheABC in the intrinsic resistance of A. hydrophila ATCC 7966^T and to delineate its substrate specificity by inactivation of the aheB gene and subsequent AheABC complementation experiments.

At first, the transcription of the aheB gene in A. hydrophila ATCC 7966^T (collection of Institut Pasteur, France) was assessed by reverse transcription (RT)-PCR amplification. RNA extracts (2 ng) were prepared from logarithmic and late-growth-phase cultures in Mueller-Hinton (MH) broth, with an SV Total RNA Isolation kit that includes a DNase treatment (Promega, France). The oligonucleotides used, AheB1F1 and MotifD1 (Table 1), targeted an internal fragment of aheB (Fig. 1). RT-PCR experiments were carried out with and without (as control) reverse transcriptase in a single RT-PCR system tube, using an AccessQuick RT-PCR kit and RT-PCR conditions as recommended by the manufacturer (i.e., one RT step of 45°C for 45 min and then 40 cycles of 94°C for 30 s, 60°C for 1 min, and 68°C for 1 min) (Promega). An RT-PCR fragment with the expected size of 947 bp was obtained for cells grown at both growth phases, demonstrating that aheB was constantly transcribed in A. hydrophila ATCC 7966^T (data not shown). Further analysis by Northern blotting and/or quantitative RT-PCR would be necessary to evaluate expression variations at different growth phases, as previously shown for mexB in Pseudomonas aeruginosa (6).

View this table: [in this window] [in a new window]

TABLE 1. Primers used for PCR amplification

Since aheB was expressed in cells grown in standard laboratory medium, in contrast to other pumps (13, 16), its inactivation could be performed to examine the resulting hypersensitive phenotype. Thus, two PCR products with restriction sites at their ends were amplified from the aheB gene, i.e., the amplicon A, using the primer pairs motifAF_KpnI and motifAR_SalI and the amplicon D, using the primer pairs motifDF_BamHI and motifDR_SphI (Table 1). The digested A and D fragments were ligated with the aph3' gene (conferring kanamycin resistance [Kan^r]) amplified by the primer pair kan1_SalI and kan2_BamHI from the pTnModOKan plasmid (Table 1 and Fig. 1) (4). The resulting AKD fragment was inserted into the KpnI and SphI double-digested plasmid pEX19Gm, generating the pEX-AKD plasmid. This vector was introduced by electroporation into the E. coli strain SM10 (Belgian Coordinated Collections of Microorganisms, Belgium), which is able to trans mobilize plasmids containing an oriT transfer origin, such as pEX19Gm (10). Conjugation experiments between the recombinant E. coli SM10 as the donor strain and A. hydrophila (intrinsically ampicillin resistant) as the recipient strain were performed by using a filter-mating procedure (3). A. hydrophila transconjugants were obtained on selective MH agar medium supplemented with kanamycin (50 mg/liter) plus ampicillin (100 mg/liter) at a transfer frequency of ca. 10^–5 per donor cell. However, it was found that the plasmids PEX19Gm and pEX-AKD were able to replicate in A. hydrophila, in contrast to those in P. aeruginosa (10) (data not shown). Then, aheB was inactivated by using the sacB-based strategy: the sacB gene located on pEX19Gm and pEX-AKD codes for a levansucrase that yields toxic metabolites at high sucrose concentrations (10). Accordingly, after growth on a selective medium containing a 10% lethal concentration of sucrose, one of the survivors, the aheB::kan mutant, was selected. PCR amplification experiments, followed by sequencing, revealed that the kanamycin cassette was correctly inserted in chromosomal DNA at amino acid position 220 of AheB, leading to the deletion of amino acids 221 to 361 (data not shown).

To outline the substrate specificity of the AheABC efflux pump, complementation experiments were necessary. Despite several independent experiments, cloning a PCR product of the entire aheABC operon directly into pEX19Gm remained unsuccessful. Thus, we performed a previous cloning step with Saccharomyces cerevisiae. First, using a Phusion DNA polymerase (Finnzymes, Finland), the operon was amplified with the primer pair yAheAdbt and yAheCfnR (Table 1) (Fig. 1). The resulting fragment of 5,769 bp contained XbaI and EcoRI recognition restriction sites and an usual prokaryotic ribosome binding site (GGAGG) 6 bp upstream from the ATG initiation codon (Table 1). This fragment was mixed with the linearized yeast-bacteria shuttle vector pGB6 (an unpublished vector derived from pRS316, including URA3, encoding a uracil biosynthesis enzyme, and bla_TEM-1, encoding ampicillin resistance). Cells of S. cerevisiae BY4742 (ura30; EUROpean S. cerevisiae ARchive for Functional collection, Germany) were transformed with the aheABC fragment and the pGB6 plasmid according to a one-step protocol based on an incubation of 30 min at 45°C in a medium containing thio compounds and alkali ions (2). The presence of the same 20-bp sequence at the ends of the amplicon (Table 1, primers yAheAdbt and yAheCfnR) and at the ends of the linearized vector allowed an efficient homologous recombination in yeast and led to the formation of the replicative circular plasmid pGB-AheABC. Yeast plasmids were extracted from the uracil-positive clones by a previously described procedure (19), and one of them was transferred by electroporation to E. coli SM10. After double digestion with XbaI and EcoRI, the insert of pGB-AheABC was introduced into pEX19Gm in the same orientation as the resident lacZ promoter for optimal expression, generating the pEX-AheABC plasmid. After verification by sequencing, this recombinant plasmid, which conferred gentamicin resistance due to the presence of an aacC1 determinant located on pEX19Gm was transferred by conjugation to the aheB::kan mutant. Thus, Aeromonas transconjugants were selected and cultivated on an MH medium containing ampicillin (100 mg/liter) and gentamicin (10 mg/liter).

Aeromonas strains with native or recombinant plasmids were compared first by the agar diffusion method, using all 53 available antibiotic disks (amikacin, amoxicillin, amoxicillin-clavulanic acid, ampicillin, aztreonam, cefepime, cefoperazone, cefotaxime, cefotetan, cefoxitin, cefpirome, cefsulodin, ceftazidime, cefuroxime, cephalothin, chloramphenicol, ciprofloxacin, clindamycin, colistin, doxycycline, erythromycin, fosfomycin, fusidic acid, gentamicin, imipenem, levofloxacin, lincomycin, minocycline, moxalactam, nalidixic acid, netilmicin, nitrofurantoin, nitroxolin, norfloxacin, ofloxacin, oxacillin, penicillin, pipemidic acid, piperacillin, piperacillin-tazobactam, pristinamycin, rifampin, sparfloxacin, spectinomycin, spiramycin, streptomycin, sulfamethoxazole, tetracycline, ticarcillin, ticarcillin-clavulanic acid, tobramycin, trimethoprim, and trimethoprim-sulfamethoxazole; Bio-Rad, France), corresponding to drugs currently in use for the treatment of human infections (15). Then, MICs were determined by an agar dilution method in MH medium, with a final inoculum of about 10⁴ CFU per spot (15), for the nine compounds that showed variations (cefuroxime, cefoperazone, erythromycin, lincomycin, pristinamycin, minocycline, trimethoprim, fusidic acid, and rifampin). The MICs of 10 nonantibiotic agents were also determined. Four of them gave varied results (ethidium bromide, acridine orange, benzalkonium chloride, and tributyltin), while six gave no changes (sodium dodecyl sulfate, rhodamine 6G, crystal violet, sodium deoxycholate, tetraphenylphosphonium chloride, and acriflavine) (Table 2). The differences in MICs between the wild-type A. hydrophila strain and its hypersensitive mutant did not exceed fourfold, suggesting that AheB expression occurred at a moderate level in the wild-type strain. Consequently, AheABC might not be as critical in the species-specific resistance of A. hydrophila as AcrAB is in E. coli (23). Alternatively, these low MIC differences might be ascribed to the overproduction of other efflux pumps or a regulatory system(s) in A. hydrophila to compensate the nonfunctional AheB protein, as described for AcrB mutations in Salmonella enterica serovar Typhimurium (5). When the multicopy pEX-AheABC plasmid was introduced into the aheB::kan mutant, the same compounds were affected, but differences in MICs were often higher, reaching 33-fold for cefoperazone and 16-fold for cefuroxime, pristinamycin, and tributyltin, and thus were considered the preferential substrates of AheB (Table 2).

View this table: [in this window] [in a new window]

TABLE 2. Susceptibility to antibiotics and nonantibiotic compounds

In order to compare the substrate profiles of AheABC and AcrAB, pEX-AheABC was introduced into E. coli TG1acrAB (17). AheABC retained its substrate specificity in this heterologous host, except for rifampin and trimethoprim, which were not affected. The increases in MICs of some substrates (acridine orange and tributyltin) were lower in E. coli than in A. hydrophila strains, whereas the reverse was noted for other drugs (erythromycin, fusidic acid, and ethidium bromide). Consequently, these variations did not seem to be related to different levels of AheABC expression in both bacteria but rather resulted from differences in outer-membrane permeability, as previously suggested for MexAB-OprM in E. coli and P. aeruginosa (22). MIC variations for the two E. coli isogenic acrAB and acrAB(pUCAcrAB) strains (17) were higher than those for the acrAB and acrAB(pEXAheABC) strains for all AheABC substrates except pristinamycin and trimethoprim (Table 2). Thus, even if both RND pumps share sequence homologies, AheABC appears to have a narrower range of substrates than AcrAB-TolC (23). Indeed, in contrast to the latter pump, AheABC did not extrude acriflavine and quinolones, although RND family exporters are commonly involved in fluoroquinolone resistance in gram-negative bacteria (18). Similarly, AheABC did not accommodate bile salts, due maybe to the fact that the usual environment of this bacteria is not, as for E. coli, the human digestive tract (1). In contrast, AcrAB exported tributyltin much more efficiently than AheABC did, although this antifouling agent is a common pollutant of water sediments that can occasionally contaminate the Aeromonas sp. ecosystem (12).

The addition of PAβN (Sigma-Aldrich, France) (14) did not modify the MICs of some AheABC substrates (cefuroxime, cefoperazone, lincomycin, ethidium bromide, and benzalkonium chloride), whereas it strongly decreased the MICs of others, whether they were preferential substrates of this pump or not (Table 2). The considerable potentiation of some compounds by PAβN in the wild-type A. hydrophila strain as well as in its aheB::kan mutant suggested that this inhibitor might block an additional RND efflux system(s).

In conclusion, this report is the first functional analysis of a multidrug efflux pump belonging to the RND family in Aeromonas spp. The AheABC system is involved in the MDR phenotype of A. hydrophila, albeit at low levels. However, inhibition tests using PAβN indicate that other RND-type efflux pumps also contribute to the intrinsic drug resistance of this species. Further experiments, facilitated by the methodology developed in this work, are warranted to explore the type of transport, substrate profile, and regulation mechanisms of these systems.

Nucleotide sequence accession number. The nucleotide sequence of the 6,554-bp fragment containing the aheRABC genes of A. hydrophila ATCC 7966^T has been deposited in the GenBank/EMBL sequence database under accession number EF613320.

 
We thank A. Yamaguchi (University of Osaka, Japan), H. Schweizer (Colorado State University, CO), G. J. Zylstra (Rutgers University, New Brunswick, NJ), and M. Bonneu (University of Bordeaux 2, France) for the gifts of E. coli TG1acrAB with and without the pUCAcrAB, pEX19Gm, pTnModOKan, and pGB6 plasmids, respectively. We thank C. Vidaillac for helpful discussion.

This work was supported by a grant from the French Research and Technology Minister.

 
* Corresponding author. Mailing address: CNRS UMR 5234, Université Bordeaux 2, 146 rue Léo Saignat, 33076 Bordeaux cedex, France. Phone: 33-5-57-57-10-75. Fax: 33-5-56-90-90-72. E-mail: corinne.arpin{at}bacterio.u-bordeaux2.fr

Published ahead of print on 11 February 2008.

Top ABSTRACT TEXT REFERENCES

 

1
1. Abbott, S. L. 2003. Aeromonas, p. 701-705. In P. R. Murray, E. J. Baron, M. A. Pfaller, J. H. Jorgensen, and R. H. Yolken (ed.), Manual of clinical microbiology, 8th ed. AMS Press, Washington, DC.
2
2. Chen, D. C., B. C. Yang, and T. T. Kuo. 1992. One-step transformation of yeast in stationary phase. Curr. Genet. 21:83-84.[CrossRef][Medline]
3
3. Courvalin, P., F. Goldstein, A. Philippon, and J. Sirot (ed.). 1985. L'antibiogramme. MPC-Vidéom ed. Paris, France.
4
4. Dennis, J. J., and G. J. Zylstra. 1998. Plasposons: modular self-cloning minitransposon derivatives for rapid genetic analysis of gram-negative bacterial genomes. Appl. Environ. Microbiol. 64:2710-2715.[Abstract/Free Full Text]
5
5. Eaves, D. J., V. Ricci, and L. J. Piddock. 2004. Expression of acrB, acrF, acrD, marA, and soxS in Salmonella enterica serovar Typhimurium: role in multiple antibiotic resistance. Antimicrob. Agents Chemother. 48:1145-1150.[Abstract/Free Full Text]
6
6. Evans, K., and K. Poole. 1999. The MexA-MexB-OprM multidrug efflux system of Pseudomonas aeruginosa is growth-phase regulated. FEMS Microbiol. Lett. 173:35-39.[CrossRef][Medline]
7
7. Giraud, E., G. Blanc, A. Bouju-Albert, F. X. Weill, and C. Donnay-Moreno. 2004. Mechanisms of quinolone resistance and clonal relationship among Aeromonas salmonicida strains isolated from reared fish with furunculosis. J. Med. Microbiol. 53:895-901.[Abstract/Free Full Text]
8
8. Goñi-Urriza, M., C. Arpin, M. Capdepuy, V. Dubois, P. Caumette, and C. Quentin. 2002. Type II topoisomerase quinolone resistance-determining regions of Aeromonas caviae, A. hydrophila, and A. sobria complexes and mutations associated with quinolone resistance. Antimicrob. Agents Chemother. 46:350-359.[Abstract/Free Full Text]
9
9. Goñi-Urriza, M., M. Capdepuy, C. Arpin, N. Raymond, P. Caumette, and C. Quentin. 2000. Impact of an urban effluent on antibiotic resistance of riverine Enterobacteriaceae and Aeromonas spp. Appl. Environ. Microbiol. 66:125-132.[Abstract/Free Full Text]
10
10. Hoang, T. T., R. R. Karkhoff-Schweizer, A. J. Kutchma, and H. P. Schweizer. 1998. A broad-host-range Flp-FRT recombination system for site-specific excision of chromosomally-located DNA sequences: application for isolation of unmarked Pseudomonas aeruginosa mutants. Gene 212:77-86.[CrossRef][Medline]
11
11. Janda, J. M., and S. L. Abbott. 1998. Evolving concepts regarding the genus Aeromonas: an expanding panorama of species, disease presentations, and unanswered questions. Clin. Infect. Dis. 27:332-344.[Medline]
12
12. Jude, F., C. Arpin, C. Brachet-Castang, M. Capdepuy, P. Caumette, and C. Quentin. 2004. TbtABM, a multidrug efflux pump associated with tributyltin resistance in Pseudomonas stutzeri. FEMS Microbiol. Lett. 232:7-14.[CrossRef][Medline]
13
13. Kohler, T., M. Michea-Hamzehpour, U. Henze, N. Gotoh, L. K. Curty, and J. C. Pechere. 1997. Characterization of MexE-MexF-OprN, a positively regulated multidrug efflux system of Pseudomonas aeruginosa. Mol. Microbiol. 23:345-354.[CrossRef][Medline]
14
14. Lomovskaya, O., and W. Watkins. 2001. Inhibition of efflux pumps as a novel approach to combat drug resistance in bacteria. J. Mol. Microbiol. Biotechnol. 3:225-236.[Medline]
15
15. Members of the SFM Antibiogram Committee. 2003. Comité de l'Antibiogramme de la Société Francaise de Microbiologie report 2003. Int. J. Antimicrob. Agents 21:364-391.[CrossRef][Medline]
16
16. Morita, Y., Y. Komori, T. Mima, T. Kuroda, T. Mizushima, and T. Tsuchiya. 2001. Construction of a series of mutants lacking all of the four major mex operons for multidrug efflux pumps or possessing each one of the operons from Pseudomonas aeruginosa PAO1: MexCD-OprJ is an inducible pump. FEMS Microbiol. Lett. 202:139-143.[CrossRef][Medline]
17
17. Nishino, K., and A. Yamaguchi. 2001. Analysis of a complete library of putative drug transporter genes in Escherichia coli. J. Bacteriol. 183:5803-5812.[Abstract/Free Full Text]
18
18. Poole, K. 2005. Efflux-mediated antimicrobial resistance. J. Antimicrob. Chemother. 56:20-51.[Abstract/Free Full Text]
19
19. Robzyk, K., and Y. Kassir. 1992. A simple and highly efficient procedure for rescuing autonomous plasmids from yeast. Nucleic Acids Res. 20:3790.[Free Full Text]
20
20. Saier, M. H., Jr., and I. T. Paulsen. 2001. Phylogeny of multidrug transporters. Semin. Cell. Dev. Biol. 12:205-213.[CrossRef][Medline]
21
21. Seshadri, R., S. W. Joseph, A. K. Chopra, J. Sha, J. Shaw, J. Graf, D. Haft, M. Wu, Q. Ren, M. J. Rosovitz, R. Madupu, L. Tallon, M. Kim, S. Jin, H. Vuong, O. C. Stine, A. Ali, A. J. Horneman, and J. F. Heidelberg. 2006. Genome sequence of Aeromonas hydrophila ATCC 7966^T: jack of all trades. J. Bacteriol. 188:8272-8282.[Abstract/Free Full Text]
22
22. Srikumar, R., T. Kon, N. Gotoh, and K. Poole. 1998. Expression of Pseudomonas aeruginosa multidrug efflux pumps MexA-MexB-OprM and MexC-MexD-OprJ in a multidrug-sensitive Escherichia coli strain. Antimicrob. Agents Chemother. 42:65-71.[Abstract/Free Full Text]
23
23. Sulavik, M. C., C. Houseweart, C. Cramer, N. Jiwani, N. Murgolo, J. Greene, B. DiDomenico, K. J. Shaw, G. H. Miller, R. Hare, and G. Shimer. 2001. Antibiotic susceptibility profiles of Escherichia coli strains lacking multidrug efflux pump genes. Antimicrob. Agents Chemother. 45:1126-1136.[Abstract/Free Full Text]

---

Antimicrobial Agents and Chemotherapy, April 2008, p. 1559-1563, Vol. 52, No. 4
0066-4804/08/$08.00+0     doi:10.1128/AAC.01052-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

This article has been cited by other articles:

• Picao, R. C., Poirel, L., Demarta, A., Petrini, O., Corvaglia, A. R., Nordmann, P. (2008). Expanded-Spectrum {beta}-Lactamase PER-1 in an Environmental Aeromonas media Isolate from Switzerland. Antimicrob. Agents Chemother. 52: 3461-3462 [Full Text]  

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hernould, M. Articles by Arpin, C. Search for Related Content PubMed PubMed Citation Articles by Hernould, M. Articles by Arpin, C.